News Detail

New Delhi, 29 April 2024: The Indian pharmaceutical industry needs to focus on various measures including investment in incremental innovation, market and product differentiation, cost reduction and improving efficiency, partnership for technology, market access, and risk sharing......
View Details
Source : Pharmabiz
DoP
R&D
Biovantis Healthcare
generic drugs
revenue stream
Indian generic
Dr Reddy’s Laboratories
Amgen
Related News
- Counterfeiting of medical devices is a severe offense that jeopardizes human lives: Delhi HC (12-03-2025)
- Three Medicines claimed to cure ‘Urinary Stones’ and ‘Rheumatism’ seized in Telangana (12-03-2025)
- Voluntary recalls initiated after FDA testing of acne products for benzene (12-03-2025)
- NPPP, 2012 Lays down principles for regulation of drugs prices: Anupriya Patel in Rajya Sabha (12-03-2025)
- Health department orders to recall batch of ‘spurious Telma AM 40’ used for hypertension (12-03-2025)
- Zydus Life inks pact to acquire majority stake in Amplitude Surgical (12-03-2025)
- Steps taken to prioritize Research on Fungal Infections (12-03-2025)
- 1500 Pregabalin capsules seized from four places, four accused arrested (12-03-2025)
- India ranked 11th in global pharma exports in 2023: Anupriya Patel (12-03-2025)
- ED arrests 2 from Lucknow for shipping 'banned' drugs to US clients (12-03-2025)